References for this Section
1. http://www.emedicinehealth.ca
2. Brecht L, Dracup K, Moser D, Riegel B. The relationship of marital quality and psychosocial adjustment to heart disease. J Cardiovasc Nurs 1994;9:74-85.
3. Wenger N. Quality of life: can it and should it be assessed in patients with heart failure? Cardiology 1989;76:391-8?
4. Hussain KM, Kogan A, Estrada AQ, Kostady G, Foschi A, Dadkhah S.Referral pattern and outcome in men and women undergoing coronary artery bypass surgery—a critical review. Angiology 1998;49:243 –50.
5. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH.The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S.Carvedilol Heart Failure Study Group.New Engl J Med 1996;334:1349 –55.
6. Hjalmarson A, Goldstein S, Fagerberg B.Effects of controlledrelease metoprolol on total mortality, hospitalizations, and wellbeing in patients with heart failure: the Metoprolol CRyXL Randomized Intervention Trial in congestive heart failure (MERIT-HF).JAMA 2000;283:1295 –302.
7. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology.Guidelines for the diagnosis and treatment of chronic heart failure.Eur Heart J 2001;22:1527 –60.
8. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr.ACC yAHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.A report of the American College of CardiologyyAmerican Heart Association Task Force on practice guidelines. (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration with the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.Cir culation 2001;104:2996 –3007.
9. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI.Randomised trial of losartan versus captopril in patients over 65 with heart failure.Evaluation of Losartan in the Elderly Study, ELITE. Lancet 1997;349:747 –52.
10. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B.Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II.Lancet 2000;355:1582 –7.
11. CONSENSUS trial study group.Effect of enalapril on mortality in severe congestive heart failure.N Engl J Med 1987;316:1429 –35.
12. The SOLVD investigators.Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure.N Engl J Med 1991;325:293 –302.
13. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitors Trials S.Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in heart failure.JAMA 1995;273:1450 –6.
14. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group. Lancet. 2000;355(9215):1575–1581.
15. Stromberg A, Martensson J. Gender differences in patients with heart failure. European Journal of Cardiovascular Nursing. 2003;2:7-18.
16. Harjai KJ, Nunez E, Humphrey S, Turgut T, Shah M, Newman J. Does gender bia exist in the medical management of heart failure? International Journal of Cardiology. 2000;75:65-69.
17. Clinical Quality Improvement Network Investigators.Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure.. Arch Intern Med 1996;156:1669 –73.
18. Opasich C, Tavazzi L, Lucci D, Gorini M, Albanese M, Cacciatore G, Maggioni A.Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol 2000;86:353 –7.
19. Agvall B, Dahlstro¨m U.Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences.Scand J Prim Health Care win pressx.
20. Philbin EF, DiSalvo TG.Influence of race and gender on care process, resource use and outcomes in congestive heart failure. Am J Cardiol 1998;82:76 –81.
21. Clarke KW, Gray D, Hampton JR.Evidence of inadequate investigation and treatment of patients with heart failure.Br Heart J 1994;71:584 –7.
22. Ayanian JZ, Weissman JS, Chasan-Taber S, Epstein AM. Quality of care by race and gender for congestive heart failure and pneumonia.Med Care 1999;37:1260 –9.
23. The SOLVD Investigators.Adverse effects of enalapril in the studies of left ventricular dysfunction.Am Heart J 1996;131:350 –5.
24. Galvao M, Kalman J, DeMarco T, Fonarow GC, Galvin C, Ghali JK, Moskowitz RM, on behalf of the ADHERE scientific advisory committee, investigators, coordinators, and study group. Gender Differences in In-Hospital Management and Outcomes in Patients With Decompensated Heart Failure: Analysis From the Acute Decompensated Heart Failure National Registry (ADHERE). Journal of Cardiac Failure. 2006;12(2):100-107.
25. Masoudi FA, Rathore SS, Wang Y, Havranek EP, Curtis JP, Foody JM, et al. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation. 2004;110(6):724–731.
26. Adams KF, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet M, Jensen LR, Tomasko L.Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996;28:1781 –8.
27. Agvall B, Dahlstro¨m U.Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences.Scand J Prim Health Care win pressx.
28. Trupp RJ, Abraham WT. Nonpharmacologic Options for the Management of Heart Failure. Current Cardiology Reports. 2003;5:243-246.
29. Bardy GH, Lee KL, Mark DB, et al, and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352(3):225-37.
30. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews MC, and the MADIT-II Investigators. Analysis of mortality events in the Multi-Center Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol. 2004;43(8):1459-65.
31. Clarke KW, Gray D, Hampton JR.Evidence of inadequate investigation and treatment of patients with heart failure.Br Heart J 1994;71:584 –7.
32. Burns RB, McCarthy EP, Moskowitz MA, Ash A, Kane RL, Finch M.Outcomes for older men and women with congestive heart failure.J Am Geriatr Soc 1997;45:276 –80.
33. Kaye MP.The registry of the international society for heart and lung transplantation: 10th official report.J Heart Lung Transplant 1994;13:561 –70.
34. Moons P, De Geest S, Abraham I, Cleemput JV, Vanhaecke J. Symtom experience associated with maintenance immunosuppression after heart transplantation: Patients’ appraisal of side effects.Heart Lung 1998;27:315 –25.
35. Grady KL, Dracup K, Kennedy G, Moser DK, Piano M, Stevenson LW, Young JB. Team Management of Patients with Heart Failure: A statemetn for healthcare professionals from the cardiovascular nursing council of the American Heart Association. Curculation 2000;102:2443-2456.
36. Ghali JK, Kadakia S, Cooper R, et al. Precipitating factors leading to decompensation of heart failre. Arch Intern Med. 1988;148:2013-2016.
37. Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38:1290-1295.
38. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly.Ar ch Intern Med 1994;154:433 –7.
39. Ducharme A, Doyon O, White M, Rouleau JL, Brophy JM. Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ 2005;173(1):40-5.
40. Naylor M, Brooten D, Jones R, et al. Comprehensive discharge planning for the hospitalized elderly: a randomized clinical trial. Ann Intern Med. 1994;120:999-1006.
41. Taubert G, Bergmeier C, Andresen H, Senges J, Potratz J. Clinical profile and management of heart failure: rural community hospital vs.metr opolitan heart center. Eur J Heart Fail 2001;3:611 –7.
42. McMurray J, McDonagh T, Morrison CE, Dargie HJ.T rends in hospitalization for heart failure in Scotland 1980–1990.Eur Heart J 1993;14:1158 –62.
43. Doughty R, Yee T, Sharpe N, MacMahon S.Hospital admissions and deaths due to congestive heart failure in New Zealand.N Z Med J 1995;108:474 –5.
44. Reitsma JB, Mosterd A, de Craen AJM, Koster RW, van Capelle FJL, Grobbee DE, Tijssen JGP.Incr ease in hospital admission rates for heart failure in the Netherlands, 1980– 1993.Heart 1996;76:388 –92.
45. Chin MH, Goldman L.Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure.Med Care 1998;36:1033 –46.
46. Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38:1290-1295.
